Duplex Ultrasound and Vascular Laboratory Quality
Duplex ultrasound as a contract between the clinical question, the acquisition protocol, the interpreting criteria, and the laboratory quality system. The chapter sets the framework for arterial, venous, post-intervention, and aneurysm-surveillance duplex so the report can carry weight in subsequent operative decisions.
Consult corner: A bedside consult-style discussion focused on what the clinician should decide next and what not to overinterpret.
Choose the hostsDuplex as a vascular-laboratory contract
Duplex ultrasound is not a casual bedside image; in vascular surgery it is a contract between the patient’s question, the technologist’s acquisition, the interpreting physician’s criteria, and the laboratory’s quality system. The clinical indication must determine the protocol, and the protocol must determine which anatomy is interrogated, which waveforms and velocities are recorded, and what the final report can safely conclude. Professional performance guidance supports a laboratory model in which protocols, equipment settings, image acquisition, reporting, and quality review are local operating requirements built from minimum professional elements rather than improvised case-by-case habits.
A high-quality vascular laboratory therefore begins before the probe touches the patient. The request should identify the clinical problem clearly enough to select the correct lane: extracranial cerebrovascular, peripheral arterial, peripheral venous, access, bypass surveillance, aneurysm surveillance, or post-intervention follow-up. The AIUM peripheral arterial parameter frames arterial ultrasound as a complete recorded examination in which anatomy, waveforms, velocities, and clinical indication travel together, while the peripheral venous parameter similarly treats venous ultrasound as a standardized examination and recording process across DVT, reflux, and follow-up contexts without merging those indications into one algorithm.
Laboratory quality is also an accreditation and governance problem. IAC standards require facilities seeking first-time accreditation or reaccreditation to use the current published standards and distinguish required standards from explanatory guidelines that help interpretation. For the surgeon-director, this means the lab must be able to show what it does, why it does it, how it reports it, and how deviations or discordant studies are reviewed. Accreditation standards do not themselves create disease-treatment thresholds; they create the framework within which local diagnostic criteria are documented and tested.
Appropriate use is part of quality. Duplex should answer a question that the clinician can act on, and it should not be used as a reflex substitute for clinical triage. Multisociety appropriate-use work provides a scaffold for arterial duplex and physiologic testing requests, and ACR appropriateness criteria add scenario-specific imaging-selection context for chronic claudication workup, acute cold painful leg evaluation, and suspected abdominal aortic aneurysm assessment. For trainees, the practical lesson is to ask: “Will this duplex study change urgency, treatment selection, anatomic planning, or follow-up?”
A duplex report should be interpreted as the output of a specific laboratory method, not as a universal number detached from its acquisition. Protocol dependence is strongest where velocity thresholds drive decisions, where stents alter hemodynamics, and where follow-up depends on detecting change over time. The safest laboratory culture treats every report as a combination of indication, technical adequacy, grayscale findings, Doppler waveforms, velocities, comparison with prior studies, and clinical plausibility.
Carotid criteria and protocol dependence
Carotid duplex is a protocol-driven examination, not simply a peak systolic velocity search. The extracranial cerebrovascular practice parameters describe expected scanning protocol, vessel-segment coverage, Doppler measurement steps, and reporting elements for carotid and vertebral studies. The clinical value of the report depends on whether the examination has recorded the relevant segments and whether the interpreting physician can connect grayscale plaque, color Doppler appearance, spectral Doppler waveforms, and velocities into a coherent classification.
- Use the 125–230 cm/s band as the moderate stenosis evidence point only when plaque and technical context support the interpretation.
- Trigger
- ICA duplex grading.
- Branch / Endpoint
- This is a diagnostic classification threshold, not a standalone intervention threshold.
Citation - Document the grayscale, spectral Doppler, velocity, color Doppler, and stent-specific inputs that make the velocity interpretation valid.
- Trigger
- Extracranial cerebrovascular duplex examinations.
- Branch / Endpoint
- Do not reduce carotid duplex interpretation to a single PSV value.
Citation - Use CAS-specific duplex velocity criteria and angiography-validated thresholds rather than applying native-carotid criteria uncritically.
- Trigger
- Carotid stent surveillance or suspected in-stent restenosis when native-vessel SRU thresholds may not apply.
- Branch / Endpoint
- CAS surveillance requires criterion sets matched to stent haemodynamics and local laboratory validation.
Citation - Use the 2021 AHA/ASA secondary-prevention guideline as the US context for carotid imaging triage after stroke or TIA.
- Trigger
- US patients with prior stroke or TIA undergoing secondary-prevention evaluation.
- Branch / Endpoint
- Carotid intervention selection belongs in the carotid disease chapters; this chapter focuses on duplex quality and reporting inputs.
Citation
For each extracranial cerebrovascular examination, the laboratory should maintain diagnostic criteria that address grayscale images, spectral Doppler waveforms, spectral Doppler velocities, color Doppler images, and stents when present. This requirement is a guardrail against reducing carotid duplex interpretation to a single velocity. A PSV value may be useful, but it is less safe when isolated from plaque visualization, waveform context, side-to-side comparison, and whether the artery is native or stented.
The SRU consensus classification defines 50–69% internal carotid artery stenosis as PSV 125–230 cm/s with visible plaque. This is a diagnostic category, not an intervention mandate. The trainee should separate three questions at the workstation: first, what stenosis category does this lab’s validated carotid protocol assign; second, is the study technically and clinically concordant; and third, does the patient’s symptom status and stroke-prevention pathway make the finding actionable.
High-grade carotid stenosis criteria illustrate why local validation matters. In one validation context for detecting ≥80% carotid stenosis, the optimal threshold was PSV ≥450 cm/s or EDV ≥120 cm/s, with AUC 0.66. That information should not be exported uncritically into every laboratory; it teaches that thresholds are performance claims tied to comparator method, patient mix, equipment, protocol, and reader practice.
Native carotid criteria should not be applied automatically to carotid stents. Carotid artery stenting changes the duplex environment, and angiography-validated work has derived carotid-stent-specific peak-systolic and end-diastolic velocity thresholds for in-stent restenosis that are distinct from native-vessel SRU consensus thresholds. In practice, a vascular laboratory should make the report explicitly state whether the vessel is native or stented and should interpret the study using the appropriate criterion set.
European and US carotid guidance provide clinical context but do not eliminate the need for a disciplined laboratory method. ESVS 2023 supplies European framing for carotid and vertebral disease categorization and reporting, while the AHA/ASA secondary-stroke-prevention guideline supplies US context for carotid imaging triage after stroke or TIA. The duplex laboratory’s role is to produce a reliable anatomic and hemodynamic classification; the disease chapter and the treating team then integrate symptoms, timing, procedural risk, and treatment options.
Bypass, access, and venous follow-up lanes
Post-revascularization duplex is a surveillance lane, not a generic arterial scan. Lower-extremity arterial practice parameters support defined vessel coverage, transducer selection, waveform documentation, and reporting expectations, while contemporary synthesis of infrainguinal revascularization surveillance emphasizes that protocols, velocity thresholds, and schedules vary across studies and laboratories. A useful surveillance program therefore makes its local criteria explicit and compares each new study with prior studies rather than interpreting numbers in isolation.
- Patients after lower-extremity vein bypass with new clinical findings.
- Action
- Obtain a duplex study sooner than the scheduled interval whenever a clinical change is detected.
- Clinical point
- SVS 2018 follow-up practice guideline recommends earlier duplex reassessment of lower-extremity vein bypass whenever a clinical change occurs (new claudication, fall in ABI, wound issues).
- Caveat
- Clinical trigger thresholds (ABI fall magnitude, claudication-distance change) vary across centers.
Citation - Patients on chronic haemodialysis with AVF or AVG accesses.
- Action
- Implement a clinical monitoring protocol at every dialysis session; reserve adjunctive duplex/angiographic surveillance for circuits flagged by monitoring abnormalities.
- Clinical point
- 2019 KDOQI Vascular Access guideline endorses routine clinical monitoring of arteriovenous access at every dialysis session (inspection, palpation of thrill, auscultation of bruit) combined with surveillance triggers (access flow change, recirculation, abnormal venous/arterial pressures, prolonged bleeding); routine adjunctive duplex surveillance is conditionally suggested for high-risk circuits.
- Caveat
- Adjunctive duplex surveillance has not consistently improved access survival in RCTs; the recommendation is conditional and tailored to local infrastructure.
Citation - Adults evaluated for chronic venous disease with deep-venous reflux in question.
- Action
- Diagnose pathologic deep reflux only when retrograde flow exceeds 1.0 seconds in CFV/FV/popliteal segments under standardized technique.
- Clinical point
- ESVS 2022 chronic venous disease guideline defines pathologic deep venous reflux as duplex-documented retrograde flow >1.0 seconds in the common femoral, femoral, and popliteal veins in the standing position after distal augmentation.
- Caveat
- Different deep-vein cutoffs may be used in iliocaval or calf-vein segments; consult lab-specific protocol.
Citation - Post-EVAR sac and endoleak follow-up when an ultrasound-led surveillance protocol is being used.
- Action
- Track sac size and endoleak status longitudinally; escalate to cross-sectional imaging when duplex findings are uncertain or clinically discordant.
- Clinical point
- Protocolized post-EVAR surveillance visit.
- Caveat
- Single-center observational evidence supports feasibility; local protocol quality and CT back-up remain essential.
Citation
For lower-extremity vein bypass, the practical failure mode is waiting for a routine interval when the patient has already declared a clinical change. SVS follow-up guidance recommends earlier duplex reassessment when new claudication, a fall in ABI, or wound problems occur after lower-extremity vein bypass. Trainees should treat symptoms, wounds, and physiologic deterioration as surveillance accelerators, while recognizing that specific trigger thresholds vary by center.
The evidence base for vein-graft surveillance should be read with its time horizon in mind. The VGST trial’s primary endpoint analysis was conducted at 18 months after infrainguinal vein bypass, which is important because late graft failure dynamics may not be fully captured by that window. The laboratory implication is modesty: surveillance programs should be structured, but conclusions about durability and interval timing must acknowledge the limits of the studies behind them.
Hemodialysis access surveillance requires a different discipline. KDOQI emphasizes routine clinical monitoring at every dialysis session—inspection, palpation of thrill, and auscultation of bruit—combined with triggers such as access-flow change, recirculation, abnormal venous or arterial pressures, and prolonged bleeding. Adjunctive duplex surveillance is conditionally suggested for high-risk circuits, but randomized trials have not consistently shown improved access survival, so duplex should be targeted to the circuit, the clinical signal, and the local ability to act on the finding.
Peripheral venous duplex must be tied tightly to indication. For suspected DVT, the pretest-probability pathway matters: in the Wells validation cohort, adult outpatients classified as “DVT unlikely” with a negative high-sensitivity D-dimer had an approximately 0.4% 3-month venous thromboembolism event rate. For chronic venous disease, the duplex question is different; ESVS defines pathologic deep venous reflux as retrograde flow lasting more than 1.0 second in the common femoral, femoral, and popliteal veins in the standing position after distal augmentation.
Post-EVAR duplex is another specialized lane. A prospective vascular-laboratory cohort evaluated duplex ultrasound as the sole long-term surveillance modality after endovascular abdominal aortic aneurysm repair, comparing sac-size and endoleak detection against CT surveillance; this work is one observational reference point for ultrasound-led post-EVAR follow-up protocols. The practical caution is that post-EVAR reports must be designed around the surveillance question—sac behavior and endoleak detection—rather than treated as a routine abdominal screening ultrasound.
Clinical integration, follow-up, and evidence boundaries
The strongest vascular laboratories are clinically integrated but intellectually restrained. They do not allow a technically beautiful study to override the bedside, and they do not allow a compelling symptom story to excuse an incomplete examination. The report should answer the clinical question at the level supported by the protocol: diagnostic category, interval change, technical limitation, and whether another imaging modality may be more appropriate for the scenario.
Imaging selection should be explicit when duplex is not enough or when another modality is more appropriate for the clinical problem. In chronic lower-extremity claudication revascularization workup, acute lower-extremity ischemia presentation, and suspected abdominal aortic aneurysm, appropriateness criteria score imaging-modality choices such as duplex ultrasound, CTA, MRA, and angiography by clinical scenario. For the surgeon, this means duplex should be chosen because it fits the decision point, not because it is familiar or immediately available.
- Extracranial cerebrovascular duplex examinations.
- Action
- Document the grayscale, spectral Doppler, velocity, color Doppler, and stent-specific inputs that make the velocity interpretation valid.
- Clinical point
- Each report should include the required image and Doppler inputs for valid interpretation.
- Caveat
- Velocity criteria must be interpreted with plaque morphology, waveform quality, color Doppler, and stent status when present.
Citation - Lower-extremity claudication before revascularization planning.
- Action
- Use appropriateness ratings to match the modality to symptoms, prior testing, renal function, and whether intervention is being considered.
- Clinical point
- Imaging choice is scenario-specific rather than scheduled surveillance.
- Caveat
- Technical performance standards do not replace modality-selection appropriateness criteria.
Citation - Acute cold or painful lower limb with concern for acute ischemia.
- Action
- Choose imaging that answers the acute revascularization question without delaying limb-saving treatment.
- Clinical point
- Immediate diagnostic workflow, not interval surveillance.
- Caveat
- Clinical urgency and local resources determine whether duplex or cross-sectional imaging is first.
Citation - Suspected abdominal aortic aneurysm or pulsatile abdominal mass.
- Action
- Use appropriateness ratings to distinguish screening/detection, surveillance, and preoperative anatomic definition.
- Clinical point
- Diagnostic or follow-up imaging choice based on the clinical scenario.
- Caveat
- Performance-parameter documents specify how to scan; appropriateness criteria specify when each modality is suitable.
Citation
Follow-up interpretation should be comparative whenever possible. A single postoperative duplex may identify a lesion, but surveillance value often lies in change: a new waveform abnormality, a velocity shift under the same laboratory method, a sac-size trend after EVAR, or a clinical trigger that makes the prior routine schedule obsolete. Because post-revascularization protocols and velocity thresholds vary, local consistency and comparison to prior examinations are central quality practices.
The laboratory should also state boundaries clearly. AIUM parameters define minimum performance and recording elements for arterial, venous, and extracranial cerebrovascular examinations, but disease-specific treatment thresholds belong to the relevant clinical pathways. IAC standards require documented criteria and current standards use, but they do not by themselves determine whether a patient should undergo carotid intervention, dialysis access revision, venous treatment, or revascularization.
For the trainee reading duplex reports, the safest habit is to audit the conclusion before acting on it. Ask whether the indication matches the protocol, whether the required anatomy was examined, whether grayscale and Doppler data support the interpretation, whether the criterion set is appropriate for native vessel versus stent or bypass versus access, whether the finding explains the patient, and whether a change in management follows. This habit converts duplex from a list of velocities into a vascular decision tool.
References
- 1.
- 2.
- 3.ACR Appropriateness Criteria Pulsatile Abdominal Mass, Suspected Abdominal Aortic Aneurysm: 2023 Update PMID: 38040468PubMed-indexed articleClinical practice guideline2023
- 4.ACR Appropriateness Criteria Sudden Onset of Cold, Painful Leg: 2023 Update PMID: 38040470PubMed-indexed articleClinical practice guideline2023
- 5.
- 6.ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing. 2012.PubMed-indexed article2012
ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing. 2012. doi:10.1016/j.jacc.2012.02.009.
- 7.Duplex Ultrasound Surveillance after Infrainguinal Peripheral Artery Revascularisation: A Systematic Review with Narrative Synthesis. 2026.PubMed-indexed articleMeta-analysis / systematic review2026
Duplex Ultrasound Surveillance after Infrainguinal Peripheral Artery Revascularisation: A Systematic Review with Narrative Synthesis. 2026. doi:10.1016/j.ejvs.2026.03.045.
- 8.
- 9.
- 10.Carotid Duplex Velocity Criteria Recommended by the Society of Radiologists in Ultrasound and Endorsed by the Intersocietal Accreditation Commission Lack Predictive Ability for Identifying High-Grade Carotid Artery Stenosis. Annals of vascular surgery. 2019.PubMed-indexed articleRegistry / cohort2019
Carotid Duplex Velocity Criteria Recommended by the Society of Radiologists in Ultrasound and Endorsed by the Intersocietal Accreditation Commission Lack Predictive Ability for Identifying High-Grade Carotid Artery Stenosis. Annals of vascular surgery. 2019. doi:10.1016/j.avsg.2019.05.051.
- 11.The AIUM Practice Parameter for the Performance of an Ultrasound Examination of the Extracranial Cerebrovascular System. 2022.PubMed-indexed article2022
The AIUM Practice Parameter for the Performance of an Ultrasound Examination of the Extracranial Cerebrovascular System. 2022. doi:10.1002/jum.15877. PMID:34792201.
- 12.AIUM Practice Parameter for the Performance of Peripheral Arterial Ultrasound Examinations Using Color and Spectral Doppler Imaging. 2021.PubMed-indexed article2021
AIUM Practice Parameter for the Performance of Peripheral Arterial Ultrasound Examinations Using Color and Spectral Doppler Imaging. 2021. doi:10.1002/jum.15643. PMID:33555645.
- 13.
- 14.
- 15.
- 16.
- 17.Editor's Choice - ESVS 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs.PubMed-indexed articleClinical practice guideline2022
Editor's Choice - ESVS 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. doi:10.1016/j.ejvs.2021.12.024.
- 18.
- 19.The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. 2018.PubMed-indexed articleClinical practice guideline2018
The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. 2018. doi:10.1016/j.jvs.2018.04.018.
- 20.
- 21.2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. 2021.PubMed-indexed articleClinical practice guideline2021
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. 2021. doi:10.1161/str.0000000000000375.
- 22.AIUM Practice Parameter for the Performance of Peripheral Arterial Ultrasound Examination Using Color and Spectral Doppler Imaging. 2022.AIUM2022
- 23.AIUM Practice Parameter for the Performance of Extracranial Cerebrovascular Doppler Ultrasound (AIUM). 2023.AIUM2023
- 24.Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. 2023.PubMed-indexed articleClinical practice guideline2023
Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. 2023. doi:10.1016/j.ejvs.2022.04.011.
- 25.
Educational use only
AI assists this editorial workflow. Published updates are human-reviewed before publication.
Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.
Verify clinically relevant information against primary sources and current guidelines.